Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Rui Wang
Nanjing University
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
50
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Adjuvant Chemotherapy Confers Survival Benefit Only in High-Risk Pathologic Stage I Non-Squamous NSCLC: A Multicenter Prospective Cohort Study and Machine-Learning–Based Decision Tool
Number of pages: 29
Posted: 31 Oct 2025
Qixuan Feng
,
Zhiyu Wang
,
Zhe Yang
,
Hanjing Gu
,
Haoran Li
,
Yue Sun
,
Lijuan Meng
,
Yizhi Zhu
,
Gao Wen
,
Yali Jiang
,
Wei Li
,
Lin Li
, Rui Wang and
Lingxiang Liu
Nanjing Medical University, Nanjing Medical University, Nanjing Medical University, Nanjing Medical University, Nanjing Medical University, Nanjing Medical University, Nanjing Medical University, Nanjing Medical University, Nanjing Medical University - Molecular Diagnostic Laboratory of Tumor, Friendship Hospital of Ili Kazakh Autonomous Prefecture, Suzhou Xiangcheng People's Hospital - Comprehensive Cancer Center, Nanjing University, Nanjing University and Nanjing Medical University
Downloads
50
(1,063,489)
View PDF
Download
Abstract:
Adjuvant chemotherapy, Stage I, Non-small cell lung cancer, High-risk factor, Prediction model
Feedback